IV maker boosts Middle East presence
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 14/02/2014 (4358 days ago), so information in it may no longer be current.
Winnipeg-based Intelligent Hospital Systems (IHS) has beefed up its market presence in the Middle East after announcing a distribution agreement in Israel.
It already has a distributor in Saudi Arabia and a corporate presence in Turkey.
IHS is the maker of robotic intravenous automation (RIVA) units, which sell for about $1.5 million each. They are fully automated intravenous (IV) compounding systems that prepare medications for syringes and IV bags in an antiseptic environment.
The company, launched in 2006, now has 38 sales in the books, the majority of them in the U.S.
It recently sold a second unit to Children’s Hospital of Orange County in California, which was the company’s first customer. A RIVA system is scheduled for installation in Doha, Qatar, and there are installations as far away as Australia.
Randy Kehler, the global distribution manager for IHS, said the company expects sales this year from its new Israeli distributor, Tel Aviv-based Nevo Medical Ltd.
“They are aggressively pursuing the market,” Kehler said. “They approached us. They had already done the market evaluation before contacting us. They have been to Winnipeg and they brought customers here to see our technology.”
Kehler said the company is currently close to signing its first distributor in South America that would cover Mexico and Chile.
Talks are also underway with interested parties in Singapore, the Netherlands, Great Britain and Korea and Kehler said the company wants Brazil to be the next region in South America to have a distributor.
RIVA is recognized for its ability to safely and accurately prepare precise compounds in small quantities. By eliminating the possibility of human error with its robotics operation, the company has demonstrated enhanced safety results, lower cost-per-dose of medications. It also provides a complete electronic audit trail that identifies and labels every dispensed dose.
IHS is owned by a group led by Winnipeg-based Western Life Sciences Venture Fund, founded by Winnipeg businessman Kevin McGarry.
martin.cash@freepress.mb.ca